Key result
Tuberculous pericarditis is a severe condition requiring prompt initiation of anti-tuberculous therapy and appropriate timing of pericardiectomy to prevent and manage constrictive complications.
Why the study?
This article aims to review the literature on tuberculous pericarditis, its prevalence in the US, clinical manifestations, diagnosis, and treatment.
This review highlights the clinical manifestations, diagnosis, and management of tuberculous pericarditis, emphasizing the importance of early anti-tuberculous therapy to prevent constrictive pericarditis.
Tuberculous pericarditis is produced by Mycobacterium tuberculosis, accounting for 1% of all forms of tuberculosis. Its prevalence varies according to coinfection with HIV. Mortality varies between 17 and 40%. In the US, the prevalence is low compared to developing countries. This article aims to review the literature on pericarditis caused by tuberculosis (TBP), its prevalence in the US, clinical manifestations, diagnosis, and treatment. Among the most frequent clinical manifestations are dyspnea, fever, chest pain, and cough. TBP should be suspected in patients at high risk of exposure to tuberculosis. There are multiple lab tests for diagnosis, and its primary treatment is triple therapy with isoniazid, rifampin, and streptomycin or ethambutol. In case of persistent elevation of systemic venous pressure, surgical intervention is indicated. The clinical presentation was found to be variable.
No takes yet. Share an insight, caveat, or question.
Maria Isabel Gomez Coral (2022) conducted a review in Tuberculous pericarditis. Anti-tuberculous therapy and pericardiectomy was evaluated. Tuberculous pericarditis is a severe condition requiring prompt initiation of anti-tuberculous therapy and appropriate timing of pericardiectomy to prevent and manage constrictive complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: